(Press-News.org) Renowned molecular biologist Yunsun Nam, Ph.D., Professor in the Departments of Biochemistry and Biophysics and the Doris and Bryan Wildenthal Distinguished Chair in Medical Science at UT Southwestern Medical Center, is the recipient of the 2026 Edith and Peter O’Donnell Award in Biological Sciences from TAMEST. She was chosen for her groundbreaking research into how RNAs and proteins interact at the molecular level – providing key insights for gene regulation, cancer biology and RNA-based therapeutics.
Crucial cellular events rely on precise communication between proteins and RNAs. Dr. Nam’s lab is uncovering the molecular rules that govern this specificity. Her group elucidated how tiny regulatory molecules called microRNAs are selected and processed in cells, a step critical for switching specific genes “on” or “off.” Her discoveries further revealed that a molecule called heme – more commonly known for carrying oxygen in red blood cells – fine-tunes the fidelity of the Microprocessor complex, a protein machine central to microRNA biogenesis.
The Nam lab also investigates how chemical modifications such as RNA methylation can alter an RNA’s fate and reshape cellular programming. They showed how each of several RNA modification enzymes uses a distinct strategy to recognize its target. Deciphering these rules led Dr. Nam’s group to uncover a novel mechanism linking dysregulated RNA methylation to cancer.
Her innovative approach uses cutting-edge biochemistry and structural biology methods, including cryo-electron microscopy, to visualize molecular interactions. Her ability to combine the chemical findings with cellular studies and machine learning enables the group to uncover how each RNA-protein event is interpreted as a signal inside cells. This work not only deepens fundamental understanding of RNA biology but also creates new opportunities for diagnosing and treating disease, especially cancers driven by misregulated RNA pathways.
“Dr. Nam is a brilliant scientist whose discoveries have transformed how scientists think about gene regulation and opened entirely new avenues in RNA biology and cancer research,” said nominator Yuh Min Chook, Ph.D., Professor of Pharmacology and Biophysics at UT Southwestern and recipient of the 2015 O’Donnell Award in Biological Sciences. “Her structural, biochemical and genetic insights have already reshaped the field and will continue to fuel transformative advances in molecular biology. She is truly helping turn basic science into medical breakthroughs.”
Dr. Nam is one of five Texas-based researchers receiving the TAMEST 2026 Edith and Peter O’Donnell Awards. Each is chosen for their individual contributions addressing the essential role that science and technology play in society, and whose work meets the highest standards of exemplary professional performance, creativity and resourcefulness.
Since the inception of the O'Donnell Awards in 2006, nearly $2.2 million has been awarded to more than 85 recipients in the categories of medicine, engineering, biological sciences, physical sciences and technology innovation. Eighteen past recipients have gone on to be elected to the National Academies of Sciences, Engineering and Medicine, including six elected to more than one National Academy.
“The Edith and Peter O’Donnell Awards have shone a spotlight on Texas’ brightest emerging researchers who are pushing the boundaries of science and technology for the past 20 years,” said Edith and Peter O’Donnell Awards Committee Chair Margaret A. Goodell, Ph.D. (NAM, NAS), Baylor College of Medicine, who herself received the O’Donnell Award in Medicine in 2011. “Each year, these awards celebrate not only exceptional individual achievement but also the profound impact that innovative research has on communities, industries and our future. It is inspiring to witness the next generation of trailblazers making Texas a global leader in transformative discovery.”
Dr. Nam will be honored at the 20th Anniversary Edith and Peter O’Donnell Awards Dinner and Ceremony on Tuesday, February 3, 2026, and will present her research at the TAMEST 2026 Annual Conference: Pioneering Climate Innovations, taking place at the Kimpton Santo Hotel in San Antonio, Texas.
All are welcome to register to attend the ceremony and the conference. Nominations for the 2027 Edith and Peter O’Donnell Awards will open Tuesday, January 20, 2026, and close Monday, March 30, 2026, at 6 p.m. CT.
END
Dr. Yunsun Nam receives 2026 O'Donnell Award in Biological Sciences for pioneering RNA research transforming gene regulation and cancer therapy
2025-12-11
ELSE PRESS RELEASES FROM THIS DATE:
Dr. Bilal Akin wins 2026 O'Donnell Award in Engineering for transformative work in EV energy systems and industrial automation
2025-12-11
Groundbreaking electrical engineer Bilal Akin, Ph.D., Professor in the Department of Electrical and Computer Engineering at The University of Texas at Dallas, is the recipient of the 2026 Edith and Peter O’Donnell Award in Engineering from TAMEST. He was chosen for his cutting-edge advancement of sustainable and high-efficiency energy conversion systems for electric vehicles (EVs) and industrial automation.
Dr. Akin’s research focuses on making power electronics systems more efficient, reliable and sustainable, with major ...
Dr. Fan Zhang receives 2026 O'Donnell Award in Physical Sciences for groundbreaking discoveries in quantum matter and topological physics
2025-12-11
Pioneering theoretical physicist Fan Zhang, Ph.D., Professor in the Department of Physics at The University of Texas at Dallas, is the recipient of the 2026 Edith and Peter O’Donnell Award in Physical Sciences from TAMEST. He was chosen for his transformational research exploring new topological quantum matter, which has changed how we think about physics.
Dr. Zhang studies how millions of electrons in atomically thin materials interact to produce collective quantum effects such as magnetic, superconducting and topological phases. His ...
Dr. Yue Hu receives 2026 O'Donnell Award for revolutionizing energy operations with real-time AI and reinforcement learning
2025-12-11
Artificial Intelligence (AI) innovator Yue Hu, Ph.D., AI Specialist – Production Technology at bp, is the recipient of the 2026 Edith and Peter O’Donnell Award in Technology Innovation from TAMEST. She was chosen for her cutting-edge work applying AI to optimize real-time industrial processes in the energy sector.
Dr. Hu specializes in reinforcement learning (RL), an AI approach that learns by trial and error. While RL has proven powerful in fields like robotics and gaming, it had rarely been applied successfully to high-stakes oilfield operations. By combining AI with bp’s powerful computing systems, Dr. Hu has successfully applied RL ...
Greater risk that the political right falls for conspiracy theories
2025-12-11
People who lean politically to the right are more likely to fall for conspiracy theories than those on the left – but not for other types of false or misleading information. And regardless of ideology, we tend to accept political claims that align with our own beliefs. This is shown in a doctoral thesis from Linköping University, Sweden.
“Conspiracy theories can have a very strong mobilising force, as seen during the storming of the Capitol. Several of those who took part believe in conspiracy ...
JMC Publication: Insilico’s AI platforms enable discovery of potent, selective, oral DGKα inhibitor to overcome checkpoint resistance
2025-12-11
Insilico Medicine has developed a new class of small molecule inhibitors targeting diacylglycerol kinase alpha (DGKα) designed to restore T cell function and overcome resistance to immune checkpoint blockades in solid cancers. The latest results from this program have just been published in the Journal of Medicinal Chemistry, describing the discovery and comprehensive preclinical evaluation of Compound 10, a novel, potent, selective and orally administered DGKα inhibitor. The compound exhibits a differentiated pharmacokinetic and safety profile and ...
Targeting collagen signaling boosts drug delivery in pancreatic cancer
2025-12-11
Pancreatic cancer is one of the deadliest malignancies, with survival rates remaining dismally low despite major advances in oncology. One of the key reasons lies in the disease’s unique fibrotic microenvironment—a dense, collagen-rich tissue that acts as a physical and biochemical barrier, preventing drugs from reaching tumor cells effectively.
Now, a research team from Okayama University and Tohoku University has uncovered a promising new way to breach this barrier. Led by Assistant Professor Hiroyoshi Y. Tanaka from the Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama University, the group demonstrated that blocking ...
Valvular heart disease is common in cancer patients but interventions improve survival
2025-12-11
Vienna, Austria – 11 December 2025: Valvular heart disease, identified through cardiovascular imaging, is common in cancer patients. Interventions to treat valvular heart disease significantly improved survival.1 These findings were presented today at EACVI 2025, the flagship congress of the European Association of Cardiovascular Imaging (EACVI), a branch of the European Society of Cardiology (ESC).
Treatment advances have led to improved survival for patients with cancer. As patients live longer, they are at an increased risk of developing valvular heart disease after successful cancer therapy. Furthermore, it is now well recognised that certain cancer treatments can cause ...
When socially responsible investing backfires
2025-12-11
Socially responsible investors (SRIs) often see themselves as agents of social or environmental progress. They buy into polluting or “dirty” companies believing that their capital can nudge a business toward a cleaner path. Their intention is straightforward: to invest in the bad to make it good.
But a new study by finance professors at the University of Rochester, Johns Hopkins University, and the Stockholm School of Economics argues that this logic can backfire. Instead of accelerating environmental reforms, SRIs may unintentionally create incentives for firms to ...
Cuffless blood pressure technologies in wearable devices show promise to transform care
2025-12-11
Statement Highlights:
Over the past decade, the number and type of cuffless devices to measure blood pressure, such as smartwatches, rings, patches and fingertip monitors, have increased significantly.
However, many personal wearable devices have not been proven to be accurate or reliable for real world use, such as during exercise, sleep or daily activity or after taking medication that affects blood pressure. In addition, variables like arm position, skin color and how recently the device was calibrated, can also affect results and contribute to inaccurate blood pressure measurements.
More research and standardized validation protocols are needed before cuffless blood pressure technologies ...
AI-based tool predicts future cardiovascular events in patients with angina
2025-12-11
Vienna, Austria – 11 December 2025: Reduced coronary blood flow, measured with an artificial intelligence-based imaging tool, predicted future cardiovascular events in patients with suspected stable coronary artery disease.1 These findings were presented today at EACVI 2025, the flagship congress of the European Association of Cardiovascular Imaging (EACVI), a branch of the European Society of Cardiology (ESC).
Stable coronary artery disease (CAD) refers to the common syndrome of recurrent, transient episodes of chest symptoms, often manifesting as angina. Coronary computed tomography angiography (CCTA) is a non-invasive heart scan that is used as the ...